1-8 of 8
Luke Paul Akard, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy

Farhad Ravandi, MD, Camille N Abboud, MD, Luke Paul Akard, MD, Saar I. Gill, MDPhD, Jack W. Hsu, MD, Suman Kambhampati, MD, Irum Khan, MBBS, Delong Liu, MD PhD, Wendy Stock, MD, Janice W Brown, MD, Asad Bashey, MD PhD, Gautam Borthakur, MD, Courtney D. DiNardo, MDMSc, H. Kent Holland, MD, Tapan M. Kadia, MD, Hagop M. Kantarjian, MD, Lawrence E Morris, MD, Scott R Solomon, MD, Richard David Mamelok, MD, Swapna Panuganti, PhD, Rod Van Syoc, Alicia Wong, BS, Deborah Zimmerman, PhD, Melhem Solh, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1407.
https://doi.org/10.1182/blood-2018-99-117231
Published: 2018
Journal Articles

ACTR087, Autologous T Lymphocytes Expressing Antibody Coupled T-Cell Receptors (ACTR), Induces Complete Responses in Patients with Relapsed or Refractory CD20-Positive B-Cell Lymphoma, in Combination with Rituximab

Luke Paul Akard, MD, Samantha Jaglowski, MD, Steven M. Devine, MD, Matthew S. McKinney, MD, Michael Vasconcelles, MD, Heather Huet, PhD, Seth Ettenberg, PhD, Ann Ranger, PhD, Jeremy S. Abramson, MD MMSc
Journal: Blood
Blood (2017)
https://doi.org/10.1182/blood.V130.Suppl_1.580.580
Published: 2017
Journal Articles

A Phase I Study of IGN523, a Novel Anti-CD98 Monoclonal Antibody in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Dale Bixby, MD PhD, Matthew J. Wieduwilt, MD PhD, Luke Paul Akard, MD, H. Jean Khoury, MD, Pamela S. Becker, MD PhD, Edward H. Van Der Horst, PhD, William Ho, MD PhD, Jorge E. Cortes, MD
Journal: Blood
Blood (2015) 126 (23): 3809.
https://doi.org/10.1182/blood.V126.23.3809.3809
Published: 2015
Journal Articles

Resource Utilization and Perceptions of Major Molecular Response In Chronic Myeloid Leukemia (CML): Results of a Delphi Panel Study.

Alfonso Quintas-Cardama, MD, Michael Flamm, MD, PhD, Michael Lill, M.D., Michael J Thirman, Farhad Ravandi, MD, Luke Paul Akard, MD, Moshe Talpaz, MD
Journal: Blood
Blood (2010) 116 (21): 4479.
https://doi.org/10.1182/blood.V116.21.4479.4479
Published: 2010
Journal Articles

Patients (Pts) with Ph+ Chronic Myeloid Leukemia In Chronic Phase (CML-CP) with a Suboptimal Molecular Response to Imatinib (IM) Can Achieve Deeper Responses When Switched to Nilotinib

Carole Miller, MD, Sikander Ailawadhi, MD, Anand P. Jillella, MD, Jerald P. Radich, MD, Daniel J DeAngelo, MD, PhD, Stuart L Goldberg, MD, Denise Williams, MD, Felice P. Lin, PharmD, Luke Paul Akard, MD
Journal: Blood
Blood (2010) 116 (21): 2301.
https://doi.org/10.1182/blood.V116.21.2301.2301
Published: 2010
Journal Articles

The Effect of Physical Conditions on the Transportation of Peripheral Blood Progenitor (PBPC) Products.

Jan Jansen, MD, PhD., Pamela L Nolan, MT(ASCP), Margaret I Reeves, BS, Luke Paul Akard, MD, James M. Thompson, DO, Michael J Dugan, MD, Susan G Hanks, MS
Journal: Blood
Blood (2008) 112 (11): 2315.
https://doi.org/10.1182/blood.V112.11.2315.2315
Published: 2008
Journal Articles

Influence of Comorbidities on Outcomes of Autologous and Allogeneic Stem Cell Transplantation (SCT).

Kerry M. Fitzpatrick, BA, Luke Paul Akard, MD, Michael Dugan, MD, James M. Thompsom, DO, Colin L. Terry, MS, Jan Jansen, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1327.
https://doi.org/10.1182/blood.V106.11.1327.1327
Published: 2005
Journal Articles

What Is the Most Useful Information Provided to Stem Cell Transplant Recipients?.

Kerry M. Fitzpatrick, BA, Luke Paul Akard, MD, Michael Dugan, MD, Jan Jansen, MD, PhD, James M. Thompson, DO, Amy Fredericks, LMSW
Journal: Blood
Blood (2005) 106 (11): 3129.
https://doi.org/10.1182/blood.V106.11.3129.3129
Published: 2005